PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...

More than three million cataract surgeries performed in Europe annually[1] Basel, Switzerland, June 16, 2015 - Alcon, the global leader in eye care and a division of Novartis, has received European CE ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix ...

Please provide your email address to receive an email when new articles are posted on . PanOptix, which is already available in more than 70 countries, has been shown to deliver a combination of near, ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL) has surpassed more than one million ...

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...

PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics 1-4,*,**,† Clareon PanOptix Pro provides more uninterrupted ...

Clareon PanOptix Pro provides unprecedented 94% light utilization, resulting in half the light scatter of Clareon PanOptix 1,2,§,* Clareon PanOptix Pro provides more uninterrupted light distribution ...